ResMed | RMD - Umsatzerlöse

Aktienkurs
30.37
Täglich Wechseln
-0.32 -1.04%
Monatlich
-5.18%
Jährlich
-17.20%
Q2 Prognose
30.31




Der Umsatz Veränderung Datum
Ansell USD 1.03B 192.2M 2025-12
Avita Medical AUD 17.61M 805K 2025-12
Cochlear AUD 1.18B 590.35M 2025-12
CSL USD 8.33B 4.79B 2025-12
Fisher & Paykel Healthcare NZD 1.09B 9.2M 2025-09
Healius AUD 688.1M 245.8M 2025-12
Integral Diagnostics AUD 238.44M 7.19M 2024-06
Mayne Pharma AUD 212.07M 17.03M 2025-12
Nanosonics AUD 102.23M 2.8M 2025-12
Polynovo AUD 70.33M 35.75M 2025-12
Ramsay Health Care AUD 9.34B 82.2M 2025-12
Regis Healthcare AUD 667.75M 70.63M 2025-12
ResMed USD 1.42B 87.23M 2025-12
Sigma Healthcare AUD 1.68B 188.65M 2024-12
Sonic Healthcare AUD 5.45B 470M 2025-12
Telix Pharmaceuticals AUD 413.44M 103.71M 2025-12